Kilpatrick Townsend expands patent litigation team
Law firm Kilpatrick Townsend & Stockton has announced the addition of Stuart Pollack to the firm’s New York office as a partner on the patent litigation team.
Pollack joins from DLA Piper, and will reunite with former colleagues and current Kilpatrick Townsend partners Michael Furrow, April Abele Isaacson, and Brian O’Reilly who joined the firm in October 2020.
Pollack focuses his practice on high-stakes patent disputes and has won favourable judgments in several suits on behalf of drug companies under the Hatch-Waxman Act. His experience includes 16 bench and jury trials in federal district courts, nine appeals at the US Court of Appeals for the Federal Circuit, and numerous cases before the International Trade Commission and the Patent Trials and Appeals Board.
Pollack’s litigation work has also included biotechnology inventions and biological drugs, industrial chemicals, food additives, medical devices, polymers, optics, chemical reactors, and various mechanical inventions.
“Pollack will add valuable experience and depth to our growing biopharma and chemical patent litigation practice,” said Kilpatrick Townsend patent litigation team co-chairs Steve Moore and Matias Ferrario.
“We were immediately impressed with his strong track record on behalf of branded biologics and drug companies. And his collaborative spirit combined with his familiarity and strong relationship with a number of partners in the firm, made his addition to the team a natural fit and a homerun for clients.”
Pollack’s hire follows the recent additions earlier this year of patent litigation partners Bob Hollingshead in Tokyo and Washington DC, Aarti Shah in Washington, DC, Wes Overson in San Francisco, and in late 2020, patent litigation counsel Abby Markeson in Seattle.
“I am familiar with the high level of talent among the Kilpatrick Townsend patent litigators, and have seen firsthand how much biopharma clients value that talent,” said Pollack. “I look forward to bringing my industry expertise and legal experience to the table. It is an honour to be a part of a firm with an elite patent bench and an international reputation for excellence across IP.”
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories sent like this straight to your inbox
